Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
37.71
-0.47 (-1.23%)
Aug 29, 2025, 4:00 PM - Market closed
Agios Pharmaceuticals Employees
As of December 31, 2024, Agios Pharmaceuticals had 488 total employees, including 486 full-time and 2 part-time employees. The number of employees increased by 102 or 26.42% compared to the previous year.
Employees
488
Change (1Y)
102
Growth (1Y)
26.42%
Revenue / Employee
$83,760
Profits / Employee
$1,332,137
Market Cap
2.19B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 488 | 102 | 26.42% |
| Dec 31, 2023 | 386 | -7 | -1.78% |
| Dec 31, 2022 | 393 | 1 | 0.26% |
| Dec 31, 2021 | 392 | -170 | -30.25% |
| Dec 31, 2020 | 562 | 26 | 4.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AGIO News
- 27 days ago - Agios' PYRUKYND® (mitapivat) Approved for Adults with Thalassemia in Saudi Arabia - GlobeNewsWire
- 4 weeks ago - Agios Pharmaceuticals, Inc. (AGIO) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Agios Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 6 weeks ago - Agios to Host Webcast Conference Call of Second Quarter Financial Results on July 31, 2025 at 8:00am ET - GlobeNewsWire
- 7 weeks ago - Agios Appoints Dr. Jay Backstrom to Board of Directors - GlobeNewsWire
- 2 months ago - Avanzanite Announces Pan-European Partnership with Agios to Launch PYRUKYND® in Rare Blood Disorders - Business Wire
- 3 months ago - Agios to Present at Goldman Sachs 46th Annual Global Healthcare Conference on June 9, 2025 - GlobeNewsWire
- 3 months ago - Agios to Highlight Pyruvate Kinase Activation Portfolio with New Data in Rare Blood Disorders at 30th EHA Congress - GlobeNewsWire